Detalhe da pesquisa
1.
Truncated FGFR2 is a clinically actionable oncogene in multiple cancers.
Nature;
608(7923): 609-617, 2022 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35948633
2.
Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis.
Nature;
572(7770): 538-542, 2019 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31367040
3.
Modeling invasive lobular breast carcinoma by CRISPR/Cas9-mediated somatic genome editing of the mammary gland.
Genes Dev;
30(12): 1470-80, 2016 06 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27340177
4.
Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers.
Nature;
609(7929): E13, 2022 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36050473
5.
Exogenous ERα Expression in the Mammary Epithelium Decreases Over Time and Does Not Contribute to p53-Deficient Mammary Tumor Formation in Mice.
J Mammary Gland Biol Neoplasia;
24(4): 305-321, 2019 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31729597
6.
Identifying transposon insertions and their effects from RNA-sequencing data.
Nucleic Acids Res;
45(12): 7064-7077, 2017 Jul 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28575524
7.
Sorafenib synergizes with metformin in NSCLC through AMPK pathway activation.
Int J Cancer;
136(6): 1434-44, 2015 Mar 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25080865
8.
High-throughput semiquantitative analysis of insertional mutations in heterogeneous tumors.
Genome Res;
21(12): 2181-9, 2011 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21852388
9.
A tissue reconstitution model to study cancer cell-intrinsic and -extrinsic factors in mammary tumourigenesis.
J Pathol;
220(1): 34-44, 2010 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19927317
10.
Cross-species comparison of aCGH data from mouse and human BRCA1- and BRCA2-mutated breast cancers.
BMC Cancer;
10: 455, 2010 Aug 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20735817
11.
Selective inhibition of BRCA2-deficient mammary tumor cell growth by AZD2281 and cisplatin.
Clin Cancer Res;
14(12): 3916-25, 2008 Jun 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18559613
12.
Transcriptomics and Transposon Mutagenesis Identify Multiple Mechanisms of Resistance to the FGFR Inhibitor AZD4547.
Cancer Res;
78(19): 5668-5679, 2018 10 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30115694
13.
Insertional mutagenesis identifies drivers of a novel oncogenic pathway in invasive lobular breast carcinoma.
Nat Genet;
49(8): 1219-1230, 2017 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28650484
14.
PTEN Loss in E-Cadherin-Deficient Mouse Mammary Epithelial Cells Rescues Apoptosis and Results in Development of Classical Invasive Lobular Carcinoma.
Cell Rep;
16(8): 2087-2101, 2016 08 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27524621
15.
BRCA1185delAG tumors may acquire therapy resistance through expression of RING-less BRCA1.
J Clin Invest;
126(8): 2903-18, 2016 08 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27454287
16.
BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistance.
Cancer Cell;
20(6): 797-809, 2011 Dec 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22172724
17.
A high-throughput pharmaceutical screen identifies compounds with specific toxicity against BRCA2-deficient tumors.
Clin Cancer Res;
16(1): 99-108, 2010 Jan 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20008842
18.
Somatic structural rearrangements in genetically engineered mouse mammary tumors.
Genome Biol;
11(10): R100, 2010.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20942901